Thermal Analysis & X-Ray Diffraction
This unit covers two fundamental characterization pillars of pharmaceutical science. Thermal Analysis methods (TGA, DTA, DSC) reveal how a drug behaves when heated—its melting point, decomposition temperature, polymorphic transitions, and moisture content. X-Ray Diffraction methods expose the internal crystalline architecture of drug molecules at the atomic level, critically important for identifying polymorphic forms that can drastically affect a drug’s solubility, dissolution rate, and bioavailability.
Syllabus & Topics
- 1Thermogravimetric Analysis (TGA): Principle: Continuously measures the WEIGHT (mass) of a sample as a function of temperature or time while it is heated at a controlled rate in a defined atmosphere (N₂, air, O₂). Instrumentation: Thermobalance (precision microbalance inside a programmable furnace), temperature programmer, purge gas system, data recorder. Output: TGA Thermogram (weight % vs. temperature). Events Detected: Dehydration (loss of water of crystallization), Desolvation (loss of solvents), Decomposition (thermal degradation), Sublimation, Oxidation. Applications: Determining moisture/solvent content of drug substances, identifying hydrates/solvates, characterizing excipient compatibility, and determining the decomposition temperature.
- 2Differential Thermal Analysis (DTA): Principle: Measures the TEMPERATURE DIFFERENCE (ΔT) between the sample and an inert reference material (like alumina, Al₂O₃) as both are heated simultaneously at the same rate. When the sample undergoes an endothermic event (melting, dehydration—it absorbs heat), the sample temperature LAGS behind the reference (ΔT is negative, endothermic peak pointing DOWN). When the sample undergoes an exothermic event (crystallization, oxidation—it releases heat), the sample temperature EXCEEDS the reference (ΔT is positive, exothermic peak pointing UP). Instrumentation: Two thermocouples (sample + reference), programmable furnace, amplifier, recorder. Applications: Detecting polymorphic transitions, melting points, glass transitions, and decomposition events.
- 3Differential Scanning Calorimetry (DSC): Principle: Measures the HEAT FLOW (energy, in mW) required to maintain BOTH the sample and reference at the SAME temperature as they are heated simultaneously. Two Types: Heat Flux DSC (measures temperature difference and calculates heat flow—similar to DTA) and Power Compensation DSC (independently heats sample and reference with separate heaters, directly measuring the power difference). Output: DSC Thermogram (heat flow vs. temperature). Provides quantitative enthalpy data (ΔH in J/g). Applications: Precise melting point and enthalpy of fusion determination, polymorphic form identification and quantification, glass transition temperature (Tg) of amorphous drugs, purity determination (van’t Hoff method), drug-excipient compatibility studies (preformulation).
- 4X-Ray Diffraction – Origins & Crystal Basics: Origin of X-Rays: Produced when high-energy electrons strike a metal target (typically Copper, Cu Kα = 1.5418 Å) in a vacuum X-ray tube. Basic Aspects of Crystals: Crystals are solid materials with atoms arranged in a highly ordered, repeating 3D pattern (crystal lattice). The smallest repeating unit is the Unit Cell, characterized by edge lengths (a, b, c) and angles (α, β, γ). Seven Crystal Systems: Cubic, Tetragonal, Orthorhombic, Monoclinic, Triclinic, Hexagonal, Rhombohedral. Bragg’s Law: nλ = 2d sinθ. When X-rays strike crystal planes separated by distance ‘d’, constructive interference (diffraction) occurs at specific angles (θ) related to the wavelength (λ) and inter-planar spacing.
- 5X-Ray Crystallographic Techniques: Single Crystal X-Ray Diffraction: Requires growing a high-quality single crystal of the drug. A monochromatic X-ray beam is diffracted by the crystal, producing a 3D diffraction pattern. Mathematical Fourier Transform analysis converts this pattern into an electron density map, revealing the exact 3D atomic coordinates of every atom in the molecule—the gold standard for absolute structure determination. Rotating Crystal Method: The single crystal is slowly rotated in the X-ray beam to bring successive crystal planes into diffracting position. Powder X-Ray Diffraction (PXRD): The polycrystalline powder sample is irradiated with X-rays. Each randomly oriented microcrystal diffracts at its Bragg angle, producing a characteristic diffraction pattern (2θ vs. intensity plot). Each crystalline polymorph has a UNIQUE ‘fingerprint’ PXRD pattern. Applications: Polymorphic form identification and quantification, crystallinity vs. amorphous content determination, batch-to-batch consistency, and patent litigation (proving or disproving a specific crystal form).
- 6Pharmaceutical Applications of Thermal & X-Ray Methods: Polymorphism: Many drugs exist in multiple crystalline forms (polymorphs) with different melting points, solubilities, and bioavailabilities. DSC detects different melting endotherms; PXRD identifies the specific polymorph present. Example: Ritonavir Form I vs. Form II (a famous polymorph disaster). Drug-Excipient Compatibility: DSC is the primary screening tool—mixing drug + excipient and heating. Disappearance or broadening of the drug’s melting endotherm indicates a potential incompatibility. Amorphous Drugs: Amorphous forms have higher solubility but lower stability. DSC determines the Tg (glass transition temperature—below which the amorphous form is stable). PXRD shows a broad diffuse halo (no sharp crystalline peaks) for amorphous materials.
Learning Objectives
Exam Prep Questions
Q1. Why is DSC preferred over DTA in modern pharmaceutical analysis?
Differential Scanning Calorimetry (DSC) is preferred because it provides quantitative measurement of heat flow, whereas Differential Thermal Analysis (DTA) only measures temperature differences. DSC can accurately determine thermodynamic parameters such as enthalpy (ΔH), melting point, and glass transition temperature, making it highly useful for purity analysis and polymorphic characterization. In contrast, DTA gives only qualitative information about thermal events.
Q2. Why is polymorphism so important in the pharmaceutical industry?
Polymorphism refers to the ability of a drug to exist in different crystal forms with the same chemical composition but different molecular arrangements. These forms can differ significantly in solubility, dissolution rate, stability, and bioavailability, directly affecting drug performance. A change in polymorphic form can lead to reduced efficacy or manufacturing issues, as seen in cases like ritonavir, making polymorphism a critical factor in drug development and quality control.
Q3. What does a “broad halo” on a PXRD pattern mean?
In Powder X-ray Diffraction (PXRD), crystalline materials produce sharp, well-defined peaks due to their ordered lattice structure. In contrast, amorphous materials lack long-range order, causing X-rays to scatter diffusely. This results in a broad, featureless halo instead of distinct peaks. Therefore, a broad halo indicates that the material is amorphous rather than crystalline.